| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 05/20/2008 | US7374893 identifying a peptide that binds to a Co, CoPt, SmCo5 or FePt metal nanoparticle; peptide library of 7-12 residues in length expressed or displayed on the surface of bacteriophage; peptide to control the assembly of inorganic magnetic nanocrystals; microelectronics |
| 05/20/2008 | US7374892 Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases |
| 05/20/2008 | US7374891 Receptor for Advanced Glycated Endproducts (RAGE); detecting binding of ligand and protein in presence of peptide, lipid, carbohydrate; amyloid, high-throughput colorimetric assay |
| 05/20/2008 | US7374890 Methods for identifying compounds that modulate ΔTRα2 activity |
| 05/20/2008 | US7374889 Human sphingosine-1-phosphate phosphatase and inhibition methods |
| 05/20/2008 | US7374888 Detecting anti-bacillus antibody in biological samples; biological and chemical warfare agents |
| 05/20/2008 | US7374886 Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker and postoperative marker for minimal residual disease or recurrent disease in patients with a prior history of cancer |
| 05/20/2008 | US7374882 Method for base sequencing and biologically active nucleic acids |
| 05/20/2008 | US7374881 Detecting gene expression in cells, comprising trapping cell on filter or membrane, contacting cell with membrane permeation solution, dissolving membrane, recovering and analyzing messenger RNA using oligonuclelotide column |
| 05/20/2008 | US7374880 Contacting cell indicative of pathological condition from diseased individual and cell from genetically related normal individual with candidate therapeutic compounds, identifying compound that alters predetermined property of diseased cell |
| 05/20/2008 | US7374878 Process for coding odors; obtain receptors, monitor activity, classify odors |
| 05/20/2008 | US7374876 Anti-idiotypic antibody and its use in diagnosis and therapy of Hepatitis C Virus related diseases |
| 05/20/2008 | US7374875 Peptides having affinity for the gp120 viral protein and use thereof |
| 05/20/2008 | US7374874 Bacteriophages that infect Bacillus bacteria (Anthrax) |
| 05/20/2008 | US7374873 Analysis method for substance |
| 05/20/2008 | US7374764 CD33-like protein |
| 05/20/2008 | US7374760 Methods and compositions for nerve regeneration |
| 05/20/2008 | US7374756 Labeled monoclonal antibody binds Kaposi's sarcoma-associated herpesvirus (KSHV); use in diagnosis and prognosis |
| 05/20/2008 | US7374721 Chip with measuring reliability and a method thereof |
| 05/20/2008 | US7374719 Test strip for determining concentration of multiple analytes in a single fluid sample |
| 05/20/2008 | US7374544 Method and apparatus for penetrating tissue |
| 05/20/2008 | US7374536 Method for analysis of pain images |
| 05/20/2008 | US7373850 Test chamber for bi-manual lens extraction |
| 05/20/2008 | CA2611106A1 Anti-coronavirus molecules and their use in compositions and methods for treating and/or preventing infection caused by a coronavirus |
| 05/20/2008 | CA2569080A1 Anti-coronavirus molecules and their use in compositions and methods for treating and/or preventing infection caused by a coronavirus |
| 05/20/2008 | CA2527780C Isolation of sclereids |
| 05/20/2008 | CA2482186C Thermally-conductive biological assay trays |
| 05/20/2008 | CA2473759C Antibodies for detecting ecstasy-class analytes |
| 05/20/2008 | CA2419698C Compounds, antibodies, reagent kits, methods of producing antibodies, and methods of detecting analytes |
| 05/20/2008 | CA2363947C Hiv peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by hiv |
| 05/20/2008 | CA2359793C Fire detection method |
| 05/20/2008 | CA2336093C Improved method for mixing and processing specimen samples |
| 05/20/2008 | CA2326530C Test methods, devices and test kits for fertility |
| 05/20/2008 | CA2269592C Composition and method for treating plants with exogenous chemicals |
| 05/20/2008 | CA2229202C Methods for identifying antagonist or agonist to human opioid receptor-like 1 "orl1" |
| 05/20/2008 | CA2218815C Methods for the production of platinum-based linkers between labels and bio-organic molecules, for labelling bio-organic molecules, for detecting biological substances of interestand diagnostic test kits |
| 05/20/2008 | CA2214742C System and method for contraband detection using nuclear quadrupole resonance |
| 05/15/2008 | WO2008058204A1 Dna purification in a multi-stage, multi-phase microchip |
| 05/15/2008 | WO2008058170A2 Container for maintaining stabilized control solution container for single-use control solution including prior use indicator |
| 05/15/2008 | WO2008058103A2 Assays useful in determining cd38 inhibition |
| 05/15/2008 | WO2008058021A2 Methods of treating neoplastic, autoimmune and inflammatory diseases |
| 05/15/2008 | WO2008058018A2 Predicting cancer outcome |
| 05/15/2008 | WO2008058004A2 Particles containing detectable elemental code |
| 05/15/2008 | WO2008057966A2 A panel of biomarkers for peripheral arterial disease |
| 05/15/2008 | WO2008057961A2 Compositions and methods for the detection of trypanosoma cruzi infection |
| 05/15/2008 | WO2008057922A2 Limiting muscle cramps |
| 05/15/2008 | WO2008057866A2 Measuring thyroxine levels from dried blood samples using mass spectrometry |
| 05/15/2008 | WO2008057806A1 A panel of biomarkers for peripheral arterial disease |
| 05/15/2008 | WO2008057767A2 Reduction of non-specific binding in immunoassays |
| 05/15/2008 | WO2008057691A2 Snp detection and other methods for characterizing and treating bipolar disorder and other ailments |
| 05/15/2008 | WO2008057648A1 Method of detection of pathogen microorganisms or chemicals |
| 05/15/2008 | WO2008057605A2 Nuclear protein extraction medium and method of use |
| 05/15/2008 | WO2008057470A2 Identification of bitter ligands that specifically activate human t2r receptors and related assays for identifying human bitter taste modulators |
| 05/15/2008 | WO2008057437A2 Ex vivo flow cytometry method and device |
| 05/15/2008 | WO2008057434A2 Method for identifying modulators of the nrf2-keap1-are pathway |
| 05/15/2008 | WO2008057366A2 Binding surfaces for affinity assays |
| 05/15/2008 | WO2008057305A2 Assay for metastatic colorectal cancer |
| 05/15/2008 | WO2008057172A2 Organic compounds |
| 05/15/2008 | WO2008057111A2 Assay apparatuses, methods and reagents |
| 05/15/2008 | WO2008057083A1 Methods of analyzing glycomolecules |
| 05/15/2008 | WO2008057054A1 Dna complexing agents |
| 05/15/2008 | WO2008056990A1 Method and device for determining hypoxanthine in biological samples |
| 05/15/2008 | WO2008056985A1 Device for measuring the ammonia content in a gas mixture |
| 05/15/2008 | WO2008056937A1 Method and kit for determining chimerism after stem cell transplantation using mitochondrial dna microsatellites as markers |
| 05/15/2008 | WO2008056837A1 Method for fabricating a biomaterial array using photoreaction |
| 05/15/2008 | WO2008056833A1 ANTI-HUMAN Dlk-1 ANTIBODY SHOWING ANTI-TUMOR ACTIVITY IN VIVO |
| 05/15/2008 | WO2008056816A1 Suspension support for linear nucleic acid molecule, method of extending linear nucleic acid molecule and linear nucleic acid molecule specimen |
| 05/15/2008 | WO2008056693A1 Dna micro array data processing method, processing device, and processing program |
| 05/15/2008 | WO2008056543A1 Method for determination of presence or absence of peptide compound pyy3-36 |
| 05/15/2008 | WO2008056480A1 Diagnosis method for fatty liver disease, diagnosis apparatus, diagnosis program, diagnostic agent, and method for screening for therapeutic agent for fatty liver disease |
| 05/15/2008 | WO2008056361A1 A biological marker for psoriasis |
| 05/15/2008 | WO2008056317A1 Biosensor device and method for detecting molecules in an analyte |
| 05/15/2008 | WO2008056290A1 Use of arylboronic acids in protein labelling |
| 05/15/2008 | WO2008056177A1 Assay system |
| 05/15/2008 | WO2008056171A2 DEVICES AND METHODS FOR DETECTING β-HAEMATIN AND HAEMOZOIN |
| 05/15/2008 | WO2008056165A1 Saturation assay |
| 05/15/2008 | WO2008056117A1 Detection system apparatus |
| 05/15/2008 | WO2008056034A1 Stable standards for bnp immunoassays |
| 05/15/2008 | WO2008055995A2 Methods and compositions for detecting receptor ligand mimetics |
| 05/15/2008 | WO2008055702A1 Carbohydrate specific cellular immunity inducing microorganisms and fractions thereof |
| 05/15/2008 | WO2008055682A1 Method for the diagnosis of leukemia |
| 05/15/2008 | WO2008055671A2 Method for the purification of at least one target substance that is to be identified |
| 05/15/2008 | WO2008055612A1 Devices and method for electrophysical cell analyses |
| 05/15/2008 | WO2008055491A2 Diagnosis and risk assessment of pancreatic diabetes using mr-proadm |
| 05/15/2008 | WO2008055361A1 E3 UBIQUITM LIGASE MKRNL AS A MARKER FOR MAMMALIAN STEM CELL PLUπPOTENCY AND METHODS AND USES THEREOF |
| 05/15/2008 | WO2008055314A1 Thyrotropin releasing hormone receptor-orexin receptor hetero-dimers/-oligomers |
| 05/15/2008 | WO2008055313A1 Detection system and uses therefor |
| 05/15/2008 | WO2008039672A3 Rapid fatty acid assay for use in pulp pitch control |
| 05/15/2008 | WO2008036075A3 Composite particles |
| 05/15/2008 | WO2008028692A8 Method for screening drug candidates for inflammatory diseases mediated by lps-inducible cc chemokine receptor mechanism |
| 05/15/2008 | WO2008028489A3 Ip-i0 based immunological monitoring |
| 05/15/2008 | WO2008026105A3 Method for detecting candida on skin |
| 05/15/2008 | WO2008022154A3 Methods of identifying agents for treating neurological disorders |
| 05/15/2008 | WO2008017970A3 Magnetic sensor device on a microchip |
| 05/15/2008 | WO2008001279A3 Disposable assay device with removables modules and remote data transfer system |
| 05/15/2008 | WO2007139895A3 Method for modeling a disease |
| 05/15/2008 | WO2005086954A3 Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease |
| 05/15/2008 | WO2004063709A3 Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators |
| 05/15/2008 | US20080115238 Cell-based assay system comprising suppressorof fused activity for identifying an inhibitor and/or an antagonist of a hedgehog signalling pathway |
| 05/15/2008 | US20080115236 Using allelic mutation in corticosteroid-binding globulin gene (CBG) as diagnostic indicator of cushing's, eating, inflammatory and glandular disorders |